sutrovax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. sutrovax’s lead product candidate is a pneumococcal conjugate vaccine (pc

Vaxcyte, Inc. Common Stock

Bought to close all PCVX

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

abhishek bansal